glp 1 gip injections GLP-1/GIP + B12 GLP-1, GLP1/GIP, and Triple G:

And it's working on an obesity pill, too

Extreme hunger is also a sign

Whats Coming Orforglipron, Lillys oral GLP-1 (non-peptide), is in late-phase trials

In a head-to-head clinical trial comparing exenatide BID (Byetta) and exenatide QW (Bydureon), the incidence of nausea in patients treated with Byetta was 35% compared to 14% in those treated with Bydureon [119]

Given that GLP-1s carry a black box warning for thyroid tumors and additional warnings for pancreatitis and kidney problems, the lack of consistent baseline labs feels risky

The Precision Peptide Genetic Test ($99 add-on after your first month of treatment) examines 150+ genetic insights related to peptide metabolism, not just drug-metabolism enzymes